SYBX
SYNLOGIC, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.19
+2.59%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$5.80
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.04
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +42.0%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | — | -$0.04 | — | — |
| May 14, 2026 | — | $0.05 | — | — |
| Nov 13, 2025 | -$0.11 | -$0.19 | Miss -72.73% | — |
| Aug 7, 2025 | -$0.13 | -$0.04 | Beat 69.23% | — |
| Mar 6, 2025 | -$0.10 | -$0.06 | Beat 40.00% | — |
| Aug 8, 2024 | -$0.51 | $0.16 | Beat 131.37% | — |
| May 14, 2024 | -$0.80 | -$2.60 | Miss -225.00% | $8.0K |
| Mar 19, 2024 | -$1.11 | -$1.71 | Miss -54.05% | $2.8M |
| Nov 9, 2023 | -$2.55 | -$2.57 | Miss -0.78% | $393.0K |
| Aug 10, 2023 | -$3.90 | -$3.15 | Beat 19.23% | $35.0K |
| May 11, 2023 | -$3.75 | -$3.45 | Beat 8.00% | $174.0K |
| Nov 10, 2022 | -$3.45 | -$3.75 | Miss -8.70% | $678.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026